Results 211 to 220 of about 17,262,511 (380)

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Early Post-Thrombectomy MRI Markers: Temporal Evolution and Association With Reperfusion and Clinical Outcome. [PDF]

open access: yesNeurology
Luby ML   +20 more
europepmc   +1 more source

Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: Clinical characteristics, risk factors, and survival outcomes [PDF]

open access: bronze
Minghao Lin   +12 more
openalex   +1 more source

Clinical Outcomes of Conservative Treatment and Arthroscopic Repair of Rotator Cuff Tears: A Retrospective Observational Study [PDF]

open access: gold, 2016
Woo Hyung Lee   +11 more
openalex   +1 more source

Does change in focal lordosis after spinal fusion affect clinical outcomes in degenerative spondylolisthesis?

open access: diamond, 2022
Brian A. Karamian   +14 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis [PDF]

open access: bronze, 2002
Li‐Fern Hsu   +10 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Aggressive Disease and Poor Clinical Outcome in CEBPα-Mutated Acute Myeloid Leukemia Patient. [PDF]

open access: yesClin Case Rep
Alshammari AA   +5 more
europepmc   +1 more source

The Impact of Sarcopenia on Clinical Outcomes after Lumbar Decompression Surgery

open access: diamond
Yukitoshi Shimamura   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy